Home › Funds › Venrock Adviser, LLC › ORKA

Venrock Adviser, LLC position in ORKA

ORUKA THERAPEUTICS INC · Health Care

Venrock Adviser, LLC reported holding 4,148,428 shares of ORKA (ORUKA THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$394.8M, representing 11.97% of its reported portfolio and ranking #2 among its reported holdings. Venrock Adviser, LLC has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

Latest position (Q2 2026)4.15M sh
Reported value held$394.81M
Portfolio Weight11.97%
First reportedQ3 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Venrock Adviser, LLC's ORKA position evolved

Venrock Adviser, LLC first disclosed a stake in ORKA in Q3 2024 at 3,085,620 shares (US$75.6M). The position peaked in Q2 2026 at 4,148,428 shares, worth US$394.8M. Across 8 filings, Venrock Adviser, LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 4,148,428 shares valued at US$394.8M. Notable position changes include a 26% increase in Q1 2025 (shares rose 9% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 3.09M $75.63M New
Q4 2024 3.29M $63.71M Add
Q1 2025 4.15M $42.56M Add
Q2 2025 4.15M $46.50M Hold
Q3 2025 4.15M $79.77M Hold
Q4 2025 4.15M $125.74M Hold
Q1 2026 4.15M $203.48M Hold
Q2 2026 4.15M $394.81M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORKA and 13F data

ORKA (ORUKA THERAPEUTICS INC) is a Health Care company. 98 other funds we track also report a position in ORKA — the largest reported positions include Fairmount Funds Management LLC (US$352.6M), RTW INVESTMENTS, LP (US$298.7M), Paradigm Biocapital Advisors LP (US$204.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORKA

All ORKA fund holders →

FAQ

How long has Venrock Adviser, LLC held ORKA?

Venrock Adviser, LLC has disclosed ORKA holdings in 8 of the last 8 reported quarters, going back to Q3 2024.

What is Venrock Adviser, LLC's current position in ORKA?

As of Q2 2026, Venrock Adviser, LLC holds 4.15M shares of ORKA (ORUKA THERAPEUTICS INC), valued at $394.81M, representing 11.97% of its reported portfolio and ranking #2.

Has Venrock Adviser, LLC been buying or selling ORKA?

In the latest 13F filing (Q2 2026), Venrock Adviser, LLC held unchanged its position in ORKA. The position peaked in Q2 2026 at 4.15M shares.

Which other funds hold ORKA?

Other major institutional holders of ORKA include Fairmount Funds Management LLC, RTW INVESTMENTS, LP, Paradigm Biocapital Advisors LP, among 98 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.